CompletedNot Applicable

Combined Effect of Underwater Ultrasound

Turkey (Türkiye)55 participantsStarted 2025-03-25

Plain-language summary

This randomised controlled trial aims to investigate the effects of underwater ultrasound therapy and customised foot insoles in RA patients. The study evaluates the effects of the combined use of these two methods on pain, functional status and quality of life. The research aims to contribute to current treatment approaches and to demonstrate the effectiveness of innovative methods to improve the quality of life of RA patients.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \- ACR/EULAR 2010 diagnostic criteria with foot involvement and having a disease duration of less than two years were enrolled in the study over a period of three months. * with foot involvement diagnosed by a rheumatologist. Exclusion Criteria: * \- Degenerative diseases and anatomical abnormalities were excluded * if they presented in an acute symptomatic flare or they needed to use walking assistance * neurological problems, malignant process, cognitive deterioration, pregnancy, previous foot surgery and the presence of a foot wound

What they're measuring

DAS-28

Timeframe: 4 weeks

Manchester-Oxford Foot Questionnaire (MOXFQ)

Timeframe: 2 weeks

Health Assessment Questionnaire [HAQ]

Timeframe: 2 weeks

Berg Balance Test

Timeframe: 4 weeks

Trial details

NCT IDNCT06753552

SponsorKirsehir Ahi Evran Universitesi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-25

View on ClinicalTrials.gov More Rheumatoid Arthritis of Ankle trials